Buy Ingelvac Circoflex 50ml Online
We are pleased to introduce Ingelvac Circoflex 50ml, a highly effective vaccine specifically developed for the prevention of Porcine Circovirus Type 2 (PCV2) infections in pigs.
Product Overview:
Ingelvac Circoflex 50ml is a specially formulated vaccine designed to protect pigs against PCV2, a viral disease that can cause significant economic losses in swine production. This vaccine is based on the inactivated PCV2 antigen, which stimulates the pig’s immune system to provide protection against PCV2-associated diseases.
Key Features and Benefits:
- PCV2 Prevention: Ingelvac Circoflex 50ml is a reliable tool for the prevention and control of PCV2 infections in pigs. It helps reduce the incidence and severity of PCV2-associated diseases, such as porcine circovirus-associated disease (PCVAD).
- Broad Spectrum Protection: Ingelvac Circoflex 50ml provides broad-spectrum protection against various PCV2 strains, including the most prevalent genotypes. This ensures comprehensive coverage against PCV2-related diseases in swine herds.
- Immunization for Different Age Groups: Ingelvac Circoflex 50ml is suitable for piglets, growing pigs, and adult pigs, allowing for flexible vaccination strategies that can be adapted to the specific needs of the herd.
- Trusted Quality: At SwineGuard Pharmaceuticals, we prioritize the safety and efficacy of our products. Ingelvac Circoflex 50ml is manufactured under strict quality control measures, ensuring that you receive a reliable and premium vaccine that meets the highest industry standards.
- Veterinary Guidance: Ingelvac Circoflex 50ml should be administered under the guidance and supervision of a veterinarian experienced in swine health. Your veterinarian will determine the appropriate vaccination protocol based on the age, health status, and specific requirements of your pig herd.
- Worldwide Availability: Ingelvac Circoflex 50ml is widely available in many countries, making it convenient for swine producers to access and administer the PCV2 vaccine.
Vaccination Guidelines:
Ingelvac Circoflex 50ml should be administered according to the recommended vaccination protocol provided by your veterinarian. The vaccine is typically administered via intramuscular injection, and the specific dosage and timing will depend on the age and health status of the pigs.
Please Note:
- Ingelvac Circoflex 50ml is intended for use in pigs and should not be used in other animal species or humans.
- PCV2 is a significant concern in swine production, and vaccination with Ingelvac Circoflex 50ml should be part of a comprehensive herd health management program that includes appropriate biosecurity measures and overall disease prevention strategies.
Protect your swine herd from PCV2-related diseases with Ingelvac Circoflex 50ml from SwineGuard Pharmaceuticals. Experience the benefits of vaccination by reducing the incidence and severity of PCV2 infections, promoting swine health, and maximizing productivity. Consult your veterinarian to implement an effective PCV2 vaccination program tailored to the specific needs of your pig herd.
Note: Ingelvac Circoflex is a real PCV2 vaccine brand, but specific recommendations and availability may vary depending on your location and local veterinary guidelines. Always consult with a veterinarian or refer to official veterinary sources for accurate and up-to-date information regarding PCV2 vaccination in pigs.
Ingelvac Circoflex 50ml is for the active immunisation of pigs over the age of 2 weeks against Porcine Circovirus Type 2 (PCV2) to reduce mortality, clinical signs – including weight loss – and lesions in lymphoid tissues associated with PCV2 related diseases (PCVD). In addition, vaccination has been shown to reduce PCV2 nasal shedding, viral load in blood and lymphoid tissues, and duration of viraemia. Each dose of 1 ml of inactivated vaccine contains : Porcine circovirus type 2 ORF2 protein: minimum RP* 1.0, maximum RP* 3.75 (*Relative Potency – ELISA test – by comparison with a reference vaccine, Adjuvant : carbomer. Ingelvac Circoflex 50ml Ingelvac Circoflex 50ml
Onset of immunity : by 2 weeks post vaccination
Duration of immunity : at least 17 weeks.
Circoflex is for the active immunisation of pigs over the age of 2 weeks against Porcine Circovirus Type 2 (PCV2) to reduce mortality, clinical signs – including weight loss – and lesions in lymphoid tissues associated with PCV2 related diseases (PCVD). In addition, vaccination has been shown to reduce PCV2 nasal shedding, viral load in blood and lymphoid tissues, and duration of viraemia. Each dose of 1 ml of inactivated vaccine contains : Porcine circovirus type 2 ORF2 protein: minimum RP* 1.0, maximum RP* 3.75 (*Relative Potency – ELISA test – by comparison with a reference vaccine, Adjuvant : carbomer.
Onset of immunity : by 2 weeks post vaccination
Duration of immunity : at least 17 weeks.
Legal Category for Ingelvac Circoflex 50ml: POM-V
Dosage: Shake well before use. Single intramuscular injection of one dose (1 ml), irrespective of body weight. Avoid introduction of contamination during use. Vaccines devices should be used in accordance with the device instructions provided by the manufacturer. Avoid multiple broaching.
Gestation Period, lactation and fertility: Do not use during pregnancy and lactation.
Withdrawal Period Ingelvac Circoflex 50ml: Zero days
Contra Indications and special precautions: A mild and transient hyperthermia very commonly occurs on the day of vaccination. On very rare occasions anaphylactic reactions may occur and should be treated symptomatically. Only healthy animals should be vaccinated. Safety and efficacy data are available which demonstrate that this vaccine can be mixed with Boehringer Ingelheim’s Ingelvac MycoFLEX and administered at one injection site.
Package quantities for Ingelvac Circoflex 50ml: 50ml
All fridge items are shipped with an ice pack.
NOAH Datasheet for Ingelvac Circoflex 50ml
For the most up to date information about this product please look up the Summary of Product Characteristics (SPC) on the VMD webpage




Reviews
There are no reviews yet.